These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25812631)

  • 1. Effects of androgen replacement therapy on cornea and tear function in men with idiopathic hypogonadotropic hypogonadism.
    Gokce G; Hurmeric V; Mumcuoglu T; Ozge G; Basaran Y; Unal HU; Bolu E; Mutlu FM
    Postgrad Med; 2015 May; 127(4):376-80. PubMed ID: 25812631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism.
    Ozata M; Yildirimkaya M; Bulur M; Yilmaz K; Bolu E; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3372-8. PubMed ID: 8784099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of androgen replacement therapy on atherosclerotic risk markers in young-to-middle-aged men with idiopathic hypogonadotropic hypogonadism.
    Doğan BA; Karakılıç E; Tuna MM; Arduç A; Berker D; Güler S
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):422-8. PubMed ID: 25280063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.
    Guo CY; Jones TH; Eastell R
    J Clin Endocrinol Metab; 1997 Feb; 82(2):658-65. PubMed ID: 9024272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy.
    Hsieh TC; Pastuszak AW; Hwang K; Lipshultz LI
    J Urol; 2013 Feb; 189(2):647-50. PubMed ID: 23260550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of long-term gonadotropin replacement treatment on sleep in men with idiopathic hypogonadotropic hypogonadism.
    Ismailogullari S; Korkmaz C; Peker Y; Bayram F; Karaca Z; Aksu M
    J Sex Med; 2011 Jul; 8(7):2090-7. PubMed ID: 21143417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of estrogen and androgen on tear secretion and matrix metalloproteinase-2 expression in lacrimal glands of ovariectomized rats.
    Song X; Zhao P; Wang G; Zhao X
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):745-51. PubMed ID: 24334444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of idiopathic hypogonadotropic hypogonadism.
    King TF; Hayes FJ
    Curr Opin Endocrinol Diabetes Obes; 2012 Jun; 19(3):204-10. PubMed ID: 22499222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry eye disease after refractive surgery: comparative outcomes of small incision lenticule extraction versus LASIK.
    Denoyer A; Landman E; Trinh L; Faure JF; Auclin F; Baudouin C
    Ophthalmology; 2015 Apr; 122(4):669-76. PubMed ID: 25458707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic smoking on central corneal thickness, endothelial cell, and dry eye parameters.
    Sayin N; Kara N; Pekel G; Altinkaynak H
    Cutan Ocul Toxicol; 2014 Sep; 33(3):201-5. PubMed ID: 24147943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
    Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of assisted reproductive technology on ocular assessments.
    Parihar JK; Kaushik J; Jain VK; Naredi N; Raina S
    Clin Exp Optom; 2016 Nov; 99(6):575-579. PubMed ID: 27306565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should human chorionic gonadotropine treatment increase thyroid volume?
    Oguz A; Tuzun D; Sahin M; Bulbul N; Celik A; Guvenc N; Inanc E; Gul K
    Arch Endocrinol Metab; 2015 Dec; 59(6):482-6. PubMed ID: 26331230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voice changes after androgen therapy for hypogonadotrophic hypogonadism.
    Akcam T; Bolu E; Merati AL; Durmus C; Gerek M; Ozkaptan Y
    Laryngoscope; 2004 Sep; 114(9):1587-91. PubMed ID: 15475787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of basal and provocative serum prolactin in differentiating idiopathic hypogonadotropic hypogonadism and constitutional delayed puberty--a diagnostic dilemma.
    Ali L; Adeel A
    J Ayub Med Coll Abbottabad; 2012; 24(2):73-6. PubMed ID: 24397058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diurnal leptin secretion is intact in male hypogonadotropic hypogonadism and is not influenced by exogenous gonadotropins.
    Kilciler G; Ozata M; Oktenli C; Sanisoglu SY; Bolu E; Bingol N; Kilciler M; Ozdemir IC; Kutlu M
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5023-9. PubMed ID: 12414867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal therapy of male hypogonadism.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 1994 Dec; 23(4):857-75. PubMed ID: 7705324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity.
    Uncu G; Avci R; Uncu Y; Kaymaz C; Develioğlu O
    Gynecol Endocrinol; 2006 Sep; 22(9):501-5. PubMed ID: 17071534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.